angiotensin I converting enzyme
| GO Term | Evidence Code | PMID |
|---|---|---|
| kidney development |
|
|
| kidney development |
|
|
| blood vessel remodeling |
|
|
| angiotensin maturation |
|
|
| angiotensin maturation |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| actin binding |
|
|
| endopeptidase activity |
|
|
| carboxypeptidase activity |
|
|
| metallocarboxypeptidase activity |
|
|
| metalloendopeptidase activity |
|
| InterPro |
|---|
| Peptidase M2, peptidyl-dipeptidase A |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050152 | aspiration pneumonia | |
| DOID:0050848 | obstructive sleep apnea | |
| DOID:0050864 | non-arteritic anterior ischemic optic neuropathy | |
| DOID:0060224 | atrial fibrillation | |
| DOID:0080599 | Coronavirus infectious disease | |
| DOID:0080600 | COVID-19 | |
| DOID:10534 | stomach cancer | |
| DOID:10591 | pre-eclampsia | |
| DOID:10763 | hypertension | |
| DOID:10952 | nephritis |
| HPO ID | HPO Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000079 | Abnormality of the urinary system |
| HP:0000252 | Microcephaly |
| HP:0001562 | Oligohydramnios |
| HP:0002009 | Potter facies |
| HP:0002089 | Pulmonary hypoplasia |
| HP:0002093 | Respiratory insufficiency |
| HP:0002615 | Hypotension |
| HP:0004492 | Widely patent fontanelles and sutures |
| HP:0008660 | Renotubular dysgenesis |
| Disease ID | Disease Name |
|---|---|
| OMIM:267430 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026